Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727137
Status:
COMPLETED
Last Update Posted:
2024-04-12
First Post:
2023-01-25
Brief Title:
Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Study Overview
Official Title:
Analgesic Efficacy of Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the analgesic efficacy of daily single-shot adductor canal blockABC versus continuous ACB after total knee arthroplasty TKA
Detailed Description:
Patients 19-75 years old of ASA classification I-III scheduled for unilateral TKA will be enrolled and randomized into two groups single-shot ACB group and continuous ACB group In both groups participants will be administered a single-shot ACB immediately after the end of the operation The single-shot ACB group will receive two separate single-shot ACBs on the first and second postoperative day A nerve block catheter will be placed in patients in the continuous ACB group which will be connected to a patient-controlled analgesia pump until the second postoperative day The primary outcome of this study is the average NRS pain score at rest from the end of surgery to 2 days after surgery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None